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 23 
       With the improved anatomical success rate of surgery for rhegmatogenous 24 
retinal detachment (RD), increasing attention has been directed toward the 25 
quality of postoperative vision. 1-6 Even after the successful retinal reattachment, 26 
the postoperative visual function may be unsatisfactory in some cases. In 27 
addition to the traditional objective assessments of patients, such as clinical 28 
examinations and laboratory data collection, subjective assessment of the daily 29 
activities and well-being of patients has become increasingly important in recent 30 
medical practice. For the quantitative evaluation of the vision-related quality of life 31 
(VR-QOL), the 25-Item National Eye Institute Visual Function Questionnaire 32 
(VFQ-25) 7 has been used to track the outcome of many ocular diseases such as 33 
cataract, glaucoma, age-related macular degeneration, epiretinal membrane, 34 
diabetic retinopathy, keratoconus, and macular hole.8-16 As RD is an acute-onset, 35 
unstable, and progressive disease, it is difficult to evaluate preoperative VR-QOL 36 
in patients with RD. On the other hand, assessment of postoperative daily 37 
activities and well-being of patients after RD surgery are feasible and of clinical 38 
importance. To the best of our knowledge, however, no reports have addressed 39 
VR-QOL in patients after RD surgery. We conducted the current prospective 40 
study to evaluate VR-QOL and visual function after surgery for RD. 41 
 42 
Methods 43 
Patients 44 
       We included 51 eyes of 51 consecutive patients with RD who were 45 
successfully treated with scleral buckling procedure or pars plana vitrectomy. 46 
Surgery was performed at our clinic by an experienced vitreoretinal surgeon 47 
(F.O.) from January 2006 through February 2007. There were 38 males and 13 48 
females, and their age averaged 51.9 ± 13.8 years (mean ± SD). The control 49 
group comprised 46 age-matched normal subjects (age 52.3 ± 3.9 years). We 50 
conducted this study in accordance with the tenets of the Declaration of Helsinki, 51 
and the study protocol was approved by the institutional review committees of 52 
Tsukuba University Hospital. Prior to inclusion in the study, all patients provided 53 
written informed consent after the nature of the study was explained to them. 54 
Exclusion criteria included previous history of ocular surgery in the study eye and 55 
ophthalmic disorders except for refractive errors. Eyes with complicated 56 
vitreoretinal disease such as proliferative vitreoretinopathy and RD resulting from 57 
giant retinal tears, macular hole, or ocular trauma were also excluded. The 58 
following preoperative information was obtained for each patient: age, gender, 59 
logarithm of the minimum angle of resolution best-corrected visual acuity 60 
(logMAR BCVA), type of detachment, number of retinal breaks, and clock hours 61 
of detachment. Data regarding characteristics of patients with RD and normal 62 
controls are presented in Table 1. Age and gender did not significantly differ 63 
between both groups. The indications for pars plana vitrectomy included RD for 64 
horseshoe tears due to posterior vitreous detachment, while the indications for 65 
scleral buckling included detachment caused by atrophic hole with lattice 66 
degeneration.  67 
       LogMAR BCVA and contrast sensitivity were obtained at 6 months 68 
postoperatively. We tested 2 indices of contrast sensitivity function; contrast 69 
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sensitivity using CSV-1000E chart and low contrast visual acuity using 70 
CSV-1000LanC10% chart (Vector Vision Co., Greenville, OH). These tests were 71 
performed with the best spectacle correction. 72 
       The CSV-1000E, which was used to test contrast sensitivity, provides a 73 
fluorescent luminance source that retroilluminates a translucent chart and 74 
automatically calibrates to 85 cd/m2. Four spatial frequencies, namely, 3, 6, 12 75 
and 18 cycles/degree (cpd), were present, and each spatial frequency included 8 76 
different levels of contrast. The test was performed monocularly in the undilated 77 
state at 2.5 m. With the patients’ manifest refraction in place, the patients 78 
identified the rows and 8 columns of patches. The patients were asked to identify 79 
the grating pattern in each column. The contrast level of the last correct response 80 
was recorded as the contrast threshold in logarithmic values.17 From the data 81 
obtained by CSV-1000E, the area under the log contrast sensitivity function 82 
(AULCSF) was calculated according to the method of Applegate et al.18 The log 83 
of contrast sensitivity was plotted as a function of log spatial frequency, and 84 
third-order polynomials were fitted to the data. The fitted function was integrated 85 
between the fixed log spatial frequency limits of 0.48 (corresponding to 3cpd) and 86 
1.26 (18cpd), and the resulting value was defined as the AULCSF. 87 
       The CSV-1000LanC10%, which was used to evaluate low contrast visual 88 
acuity, is based on the Early Treatment Diabetic Retinopathy Study (ETDRS) 89 
chart (The Lighthouse, New York, NY). Although the original ETDRS chart uses 90 
alphabets as optotypes under 100% high contrast, this system uses Landolt rings 91 
as optotypes under 10% low contrast. This test was performed monocularly with 92 
undilated pupils at 2.5 m distance. 93 
       The patients’ eyes were classified into 2 groups based on the type of surgical 94 
procedures; 33 eyes were treated with pars plana vitrectomy and 18 eyes with 95 
scleral buckling. The buckling surgery consisted of cryopexy and circumferential 96 
silicone sponge buckling (#506, MIRA, Walthom, MA). The encircling was 97 
performed using a silicone band (#240, MIRA) or a silicone sponge (#506G, 98 
MIRA). Subretinal fluid drainage and sulfur hexafluoride (SF6) gas injection was 99 
performed when required. Combined cataract surgery and standard 20-gauge 100 
vitrectomy was performed in all patients in the pars plana vitrectomy group. The 101 
surgical technique comprised a vitrectomy that released vitreous traction around 102 
the breaks, internal drainage of the subretinal fluid, a total gas-fluid exchange 103 
using 20% SF6, and endolaser photocoagulation. In both treatment groups, 104 
patients who were injected with gas were instructed to maintain a facedown 105 
position during the first 1 postoperative week. 106 
The 25-item National Eye Institute Visual Function Questionnaire (VFQ-25) 107 
       The patients were requested to self-administer VFQ-25 at 6 months 108 
postoperatively to assess VR-QOL. Preoperative evaluation of VFQ-25 was not 109 
performed because RD is a rapid-onset ocular disorder. The research staff 110 
explained the questionnaire to the patients, verbally administered the instructions, 111 
and provided assistance when required. The completed questionnaires were 112 
reviewed for missing data by the research staff. The patients with RD and normal 113 
controls were instructed to rate the level of difficulty in terms of particular visual 114 
symptoms or vision-related daily activities.  115 
       VFQ-25 is composed of 12 vision-targeted scales: general health, general 116 
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vision, ocular pain, near activities, distance activities, social functioning, mental 117 
health, role difficulties, dependency, driving, color vision, and peripheral vision. 7 118 
Each scale consisted of a minimum of 1 and maximum of 4 items. The standard 119 
algorithm was used to calculate the scale scores, which have a possible range 120 
from 0 to 100. 7 The higher the score, the better the VR-QOL pertinent to that 121 
specific symptom/activity. The composite score was calculated by averaging the 122 
scores of 11 subscales; the “general health” subscale was excluded.7 In this study, 123 
the Japanese version of VFQ-25 was used which was modified to suit the 124 
Japanese culture and lifestyle. This modified VFQ-25 has been assessed for its 125 
reliability and validity and has been proven to measure VR-QOL accurately in 126 
Japanese individuals.8 127 
Statistical analysis 128 
       The mean scores and standard deviations were calculated for each VFQ-25 129 
subscale as well as for the VFQ-25 composite score. A Mann-Whitney U test was 130 
performed to compare each subscale score and composite score between the 131 
RD group and normal controls. The same test was also used to compare age, 132 
visual acuity, contrast sensitivity, and the VFQ-25 composite score between the 133 
pars plana vitrectomy group and scleral buckling group. The relationship between 134 
questionnaire scores and visual acuity, contrast sensitivity, age, number of retinal 135 
breaks, and clock hours of detachment were examined by the Spearman rank 136 
correlation test. To correlate visual acuity with the questionnaire score, the 137 
logMAR BCVA worse than 1.6 was determined as follows: counter fingers, 2.00; 138 
hand motions, 2.30; and light perception, 2.60.19,20 All tests were considered 139 
statistically significant if P < 0.05. The analyses were carried out using StatView 140 
(version 5.0, SAS Inc., Cary, NC). 141 
 142 
Results 143 
       All patients had unilateral RD and surgery only in the RD eye during the 144 
perioperative and 6-month postoperative period. No significant intraoperative and 145 
postoperative complications were observed, such as subretinal hemorrhage, 146 
persistent elevation of intraocular pressure for more than 3 days, cystoid macular 147 
edema, and choroidal detachment. Retinal reattachment was attained at initial 148 
operation in all eyes. In the scleral buckling group, SF6 gas was injected in 4 149 
patients (22.2%), and subretinal fluid drainage was performed in 9 patients 150 
(50.0%), and there was no cataract formation. In the pars plana vitrectomy group, 151 
20% SF6 gas was injected in all patients. At 6 months postoperatively, logMAR 152 
BCVA was 0.06 ± 0.23, AULCSF was 0.97 ± 0.25, and low contrast visual acuity 153 
was 0.50 ± 0.26. A relationship between preoperative and postoperative logMAR 154 
BCVA based on macular-on or macular-off retinal detachment status in each eye 155 
is shown in Figure 1. In all cases, RD surgery was performed in their similarly- or 156 
worse-seeing eye. The logMAR BCVA in the fellow eye was –0.07 ± 0.05. 157 
       The results of VFQ-25 subscales and the composite scores in the RD group 158 
and normal controls are shown in Table 2. The VFQ-25 composite score was 159 
significantly lower in the RD patients (80.3 ± 12.5) than in the normal controls 160 
(85.2 ± 10.2, p < 0.05). The RD group showed significantly lower scores than the 161 
normal controls in 4 subscales, near activities, mental health, dependency, and 162 
peripheral vision. 163 
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       No correlation was observed between the VFQ-25 composite score and 164 
postoperative logMAR BCVA in the operated eye (Figure 2), but the VFQ-25 165 
composite score exhibited significant correlation with AULCSF and low contrast 166 
visual acuity in the operated eye (Figure 2). The VFQ-25 composite score did not 167 
show any significant relationship with preoperative logMAR BCVA (r = –0.128, p = 168 
0.372), age (r = 0.138, p = 0.496), number of retinal breaks (r = –0.007, p = 0.966), 169 
and clock hours of detachment (r = –0.070, p = 0.641). The VFQ-25 composite 170 
score did not correlate with logMAR BCVA and the contrast sensitivity in the 171 
fellow eye.  172 
       The preoperative logMAR BCVA in the macular-off retinal detachment group 173 
(0.83 ± 0.62) was significantly worse than that in the macular-on group (-0.04 ± 174 
0.05, p < 0.0001). Further, The postoperative logMAR BCVA in the macular-off 175 
group (0.13 ± 0.26) was significantly worse than that in the macular-on group 176 
(-0.06 ± 0.06, p < 0.001). However, there was no difference between the 177 
postoperative VFQ-25 composite score in the macular-off group (78.8 ± 12.1) and 178 
that in the macular-on group (83.2 ± 13.1, p = 0.17).  179 
 180 
Discussion 181 
       As shown in the results, in patients with RD even after successful 182 
reattachment surgery, VR-QOL is at a lower level than the normal controls. 183 
Specifically, the score of 4 subscales were significantly lower in the RD group 184 
than in the normal controls, such as near activities, mental health, dependency, 185 
and peripheral vision. Although visual acuity in the RD patients was almost 186 
normal after reattachment surgery (logMAR BCVA 0.06 in this study), their 187 
VR-QOL was found to be deteriorated. Previous studies have reported that the 188 
mean VFQ-25 composite scores after surgery in patients with macular hole, 189 
epiretinal membrane and age-related macular degeneration were 82.4, 15 83.3,9  190 
and 54.4, 14 respectively. The mean VFQ-25 composite score after RD surgery in 191 
this study (80.3) was similar to those after macular hole and epiretinal membrane 192 
surgery and higher than that after macular translocation surgery for age-related 193 
macular degeneration.  194 
      We found that the VFQ-25 composite score significantly correlated with 195 
contrast sensitivity, but not with visual acuity. Visual acuity is widely recognized 196 
as a major determinant of VR-QOL, and in fact ophthalmologists rely primarily on 197 
visual acuity to plan patient management.21 Many studies have shown that visual 198 
acuity correlates with VR-QOL.9,15,20-23 However, visual acuity can be a poor 199 
predictor of many aspects of visual function.24,25 Contrast sensitivity has been 200 
shown to correlate with various aspects of activities requiring vision, including 201 
orientation, mobility, reading speed, and driving.26,27 Carta et al reported that 202 
contrast sensitivity was strongly associated with VR-QOL, even with adjustment 203 
for visual acuity among ophthalmic patients with chronic eye conditions such as 204 
age-related macular degeneration.28 In other studies, VFQ-25 responses 205 
correlated with contrast sensitivity as well as visual acuity in patients with  206 
diabetes mellitus and age-related macular degeneration.11,21 It is noteworthy that 207 
contrast sensitivity was significantly associated with VR-QOL in patients after RD 208 
surgery. 209 
       The VFQ-25 composite score correlated with visual function in the operated 210 
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eyes, but not in the fellow eyes. Since the worse- or similarly-seeing eyes were 211 
operated on in all cases in our study, these results indicate that VR-QOL was 212 
associated with visual function in the worse-seeing eye. These results are not 213 
consistent with several previous reports. Miskala et al investigated VR-QOL in 214 
patients with subfoveal choroidal neovascularization using VFQ-25, and they 215 
demonstrated that changes in the overall and subscale scores are linearly related 216 
to changes in visual acuity of the better-seeing eye but not of the worse-seeing 217 
eye.22 Deramo et al investigated VR-QOL in patients with unilateral central retinal 218 
vein occlusion and observed that the VFQ-25 responses correlated with visual 219 
acuity in the better-seeing eye.20 In other studies, the VFQ-25 responses 220 
correlated with binocular visual acuity in patients with macular hole and epiretinal 221 
membrane.9,15 A significant relationship between VR-QOL and the visual function 222 
of the worse-seeing eye has not been reported until now. At present, we do not 223 
have clear explanation for this discrepancy, but there are two speculations. First, 224 
since RD is a rapid-onset disease, patients do not have enough time to get 225 
accustomed to the condition in which daily life is largely dependent on the 226 
better-seeing eye. In case of chronic and slowly-progressive diseases, patients 227 
may gradually adjust themselves to the condition in which the function of the 228 
better-seeing eye plays a major role in daily activities. Second, the mean visual 229 
acuity in the worse-seeing eye (logMAR BCVA 0.06 in this study) was rather 230 
higher than in other vitreoretinal diseases (e.g., macular hole, age-related 231 
macular degeneration, and epiretinal membrane). It may be that small difference 232 
in visual function between the better- and worse-seeing eyes was, at least 233 
partially, responsible for the current results. 234 
       We acknowledge certain limitations of our study, including small sample size 235 
that may have influenced the relationship between visual function and VFQ-25 236 
scores. Another limitation of our study is the lack of preoperative VFQ-25 scores 237 
and scores at several times post surgery. Future studies with a larger sample size 238 
and time course of changes in VR-QOL will further facilitate our understanding of 239 
the relation between VR-QOL and visual function in patients undergoing surgery 240 
for RD. 241 
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Figure legends 337 
Figure 1. Visual acuity preoperatively and 6 months after surgery for retinal 338 
detachment.  339 
Macular off, eyes in which the fovea was involved in the retinal detachment 340 
before surgery; macular on, eyes in which the fovea was not involved.  341 
 342 
Figure 2. National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25) 343 
composite score vs. postoperative visual acuity and contrast sensitivity in the 344 
operated eye in patients with retinal detachment.  345 
(Top left) VFQ-25 composite score vs. logarithm of the minimum angle of 346 
resolution best-corrected visual acuity (logMAR BCVA): r = –0.172, p = 0.229. 347 
(Top right) VFQ-25 composite score vs. the area under the log contrast sensitivity 348 
function (AULCSF): r = 0.354, p < 0.05. (Bottom left) VFQ-25 composite score vs. 349 
low contrast visual acuity: r = –0.475, p < 0.001. 350 
